|
The following was reported to gore: on (b)(6) 2026, the patient underwent endovascular treatment of a left internal iliac artery aneurysm using a gore® excluder® iliac branch endoprosthesis (internal iliac component).After the internal iliac component was implanted, final angiography revealed a dissection in the left common iliac artery.This dissection occurred when a 12fr gore® dryseal flex introducer sheath was advanced.The physician decided to monitor the dissection.
|
|
H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may have not been able to fully investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|